Evidence map›Paper›PMID 41045297›Full record

ArticleWorld journal of microbiology & biotechnology2025

Novel degenerate PCR primers targeting the β-galactosidase gene for broad-spectrum identification of lactose-degrading bacteria.

Canting Shen, Qinglong Shu

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Canting ShenCollege of Traditional Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.
Qinglong ShuCollege of Traditional Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China. shuqinglong@126.com.

Funding

The National Natural Science Foundation of China 82560805 and 82160788
6 · The paper itself

Abstract

β-galactosidase (EC 3.2.1.23), a pivotal enzyme in lactose degradation, is widely distributed across numerous bacterial species. This study aimed to develop degenerate primers with high specificity and universality, using the β-galactosidase gene as a molecular marker to identify diverse lactose-degrading bacteria in environmental samples. High-quality β-galactosidase gene sequences belonging to glycoside hydrolase family 2 were retrieved from the NCBI and CAZY databases for sequence alignment and phylogenetic analysis. Through extensive screening and optimization of full-length sequences, a pair of primers was successfully designed for detecting environmental β-galactosidase genes. The newly developed primers were validated using four types of DNA samples, revealing the diversity of lactose-degrading bacterial communities: Human feces (2 phyla, 5 genera), Rat feces (3 phyla, 3 genera), Mouse feces (2 phyla, 6 genera), and soil (6 phyla, 13 genera). By optimizing sequences of representative strains based on the full-length target gene, this study successfully developed novel degenerate primers, providing a reference strategy for addressing the challenge of primer design for highly variable gene families. Additionally, a new molecular probe targeting the β-galactosidase gene was developed to identify diverse lactose-degrading bacteria in environmental samples. To the best of our knowledge, this is the first report of universal primers targeting the β-galactosidase gene for detecting lactose-degrading microbial communities in environmental samples.

Indexed as

Bacteriabeta-GalactosidaseDNA PrimersLactosePolymerase Chain ReactionAnimalsDNA, BacterialFecesHumansMicePhylogenyRatsSoil Microbiologybeta-GalactosidaseDNA, BacterialDNA PrimersLactoseBacteriaLactaseLactose-Degrading bacteriaΒ-Galactosidase

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.